IL17A and neoplasm: The lower tumor development in mice harboring TGF-β-DNR CD4+ T cells correlated with a reduced frequency of IL-17A+IL-22+ CD4+ T cells, whereas IL-17A-IL-22+ CD4+ T cells were unaffected.